News and Press Releases Search About the CF Foundation Public Policy Advocacy Clinical Trials Research Cystic Fibrosis Foundation Therapeutics (CFFT) Genetic Therapies (-) CFTR Modulators 2019 (-) 2015 2014 2012 2011 (-) Press Releases About the CF Foundation | CFTR Modulators | Genetic Therapies CF Foundation Celebrates FDA Approval of Orkambi as Important Advance for the CF Community Drug Targets the Underlying Cause of the Disease in People with the Most Common CF Mutation Jul. 2, 2015 | 5 min read About the CF Foundation | CFTR Modulators | Genetic Therapies Cystic Fibrosis Foundation Issues Statement on The New England Journal of Medicine Study on the Benefits of the Ivacaftor/Lumacaftor Combination Drug May. 17, 2015 | 3 min read About the CF Foundation | CFTR Modulators | Research FDA Approves Ivacaftor for Children Ages 2 to 5 with Certain Rare CF Mutations Mar. 18, 2015 | 3 min read
